Practice Guideline
doi: 10.1111/bjh.15235.
Epub 2018 May 6.
Guidelines for the use of hydroxycarbamide in children and adults with sickle cell disease: A British Society for Haematology Guideline
Affiliations
- PMID: 29732531
- DOI: 10.1111/bjh.15235
Item in Clipboard
Practice Guideline
Guidelines for the use of hydroxycarbamide in children and adults with sickle cell disease: A British Society for Haematology Guideline
Br J Haematol.
2018 May.
No abstract available
Similar articles
-
Hydroxycarbamide treatment and brain MRI/MRA findings in children with sickle cell anaemia.Br J Haematol. 2016 Oct;175(2):331-338. doi: 10.1111/bjh.14235. Epub 2016 Sep 8. Br J Haematol. 2016. PMID: 27604981
-
Hydroxyurea information for children and parents.Paediatr Nurs. 2003 Mar;15(2):40-1. doi: 10.7748/paed.15.2.40.s21. Paediatr Nurs. 2003. PMID: 12677858 Review. No abstract available.
-
The effect of hydroxcarbamide therapy on survival of children with sickle cell disease.Br J Haematol. 2013 Jun;161(6):852-60. doi: 10.1111/bjh.12323. Epub 2013 Apr 17. Br J Haematol. 2013. PMID: 23590693 Clinical Trial.
-
Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial.Lancet. 2016 Feb 13;387(10019):661-670. doi: 10.1016/S0140-6736(15)01041-7. Epub 2015 Dec 6. Lancet. 2016. PMID: 26670617 Free PMC article. Clinical Trial.
-
The role of hydroxyurea in sickle cell disease.Br J Haematol. 2003 Jan;120(2):177-86. doi: 10.1046/j.1365-2141.2003.03849.x. Br J Haematol. 2003. PMID: 12542474 Review. No abstract available.
Cited by
-
Hydroxyurea to lower transcranial Doppler velocities and prevent primary stroke: the Uganda NOHARM sickle cell anemia cohort.Haematologica. 2020 Jun;105(6):e272-e275. doi: 10.3324/haematol.2019.231407. Epub 2019 Oct 24. Haematologica. 2020. PMID: 31649130 Free PMC article. No abstract available.
-
Optimal disease management and health monitoring in adults with sickle cell disease.Hematology Am Soc Hematol Educ Program. 2019 Dec 6;2019(1):505-512. doi: 10.1182/hematology.2019000055. Hematology Am Soc Hematol Educ Program. 2019. PMID: 31808832 Free PMC article. Review.
-
Guidelines on sickle cell disease: secondary stroke prevention in children and adolescents. Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular guidelines project: Associação Médica Brasileira - 2022.Hematol Transfus Cell Ther. 2022 Apr-Jun;44(2):246-255. doi: 10.1016/j.htct.2022.01.010. Epub 2022 Feb 25. Hematol Transfus Cell Ther. 2022. PMID: 35305940 Free PMC article. No abstract available.
-
Maternal and perinatal outcomes of sickle cell disease in pregnancy: A nationwide study in France.Br J Haematol. 2025 Apr;206(4):1218-1227. doi: 10.1111/bjh.20009. Epub 2025 Feb 21. Br J Haematol. 2025. PMID: 39984807 Free PMC article.
-
Efficacy, safety, and pharmacokinetics of a new, ready-to-use, liquid hydroxyurea in children with sickle cell anemia.Blood Adv. 2023 Aug 22;7(16):4319-4322. doi: 10.1182/bloodadvances.2023010099. Blood Adv. 2023. PMID: 37171600 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
